bharat biotech
WHO assessing Covaxin data for EUL; Decision date 'to be confirmed'
Rolling data allows the WHO to start its review right away to accelerate the overall review process
Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech
The indigenous vaccine showed 63.6 per cent efficacy against the Delta variant of Covid-19
Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO
Swaminathan said WHO is reviewing Covaxin as its manufacturer Bharat Biotech is now uploading its entire data on the health body's portal
Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases
Brazil to suspend Indian COVID-19 vaccine deal as graft allegations probed
Brazilian federal prosecutors have opened an investigation into the deal, citing comparatively high prices and pending regulatory approvals
Bharat Biotech says supply price of Covaxin to Centre at Rs 150 not viable
The manufacturer said it had so far invested over Rs 500 crore 'from its own resources'
Bharat Biotech says EUL for COVAXIN submitted to WHO, approval expected by July-Sept
The WHO has given approvals to the Pfizer/BioNTech vaccine for emergency use on December 31
Govt ready to allow other companies to make Covaxin
The government has now engaged five Public Sector Undertakings to help increase production of Covaxin
Delhi blames Bharat Bio for vaccine shortage
Sisodia says pharma firm refused to supply required doses after reserve stock of vaccines exhausted
States rushing for global vaccine tenders
The officials took the cue from the Uttar Pradesh government, ruled by BJP, which was first among the states to moot global tenders